Cas no 576-19-2 ((2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid)

(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid structure

576-19-2 structure

Product Name:(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid

CAS No:576-19-2

MF:C₁₆H₂₈N₄O₄S

MW:372.482922554016

MDL:MFCD00077319

CID:38432

PubChem ID:24891762

Update Time:2025-04-18

(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid Chemical and Physical Properties

Names and Identifiers

- Biocytin
- N6-[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-lysine
- (2S)-6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-aminohexanoic acid
- Biocytin?
- H-L-Lys(Biotinyl)-OH
- H-Lys(biotinyl)-OH
- H-Lys（biotinyl）-OH（Biocytin）
- N'-Biotinyl-L-lysine
- (S)-(-)-Pindolol
- Bct,Nε-(+)-Biotinyl-L-lysine
- Biotinyl-L-lysine
- N6-[5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pentanoyl]-L-lysine
- N6-[5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-valeryl]-L-lysine
- N6-D-Biotinyl-L-lysine
- Ne-Biotynyl-L-lysine
- Bct
- Nε-(+)-Biotinyl-L-lysine
- (+)-Biocytin
- C16H28N4O4S
- epsilon-N-Biotinyl-L-lysine
- G6D6147J22
- n6-{5-[(3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl]pentanoyl}-l-lysine
- (2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanamido}-2-aminohexanoic acid
- biotinyllysin
- N6-(
- (2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid
- .epsilon.-N-Biotinyl-L-lysine
- AKOS015915827
- HY-101884
- DTXSID30973172
- DS-5744
- CHEBI:27870
- Biocytin (epsilon;-Biotinoyl-L-lysine)
- (3aS-(3aalpha,4beta,6aalpha))-N(6)-(5-(hexahydro-2-oxo-1H-thieno(3,4-d)imidazol-4-yl)-1-oxopentyl)-L-lysine
- N6-delta-Biotinyl-L-lysine
- (S)-2-amino-6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanoic acid
- BIOCYTIN [MI]
- Q864247
- L-Lysine, N6-(5-(hexahydro-2-oxo-1H-thieno(3,4-d)imidazol-4-yl)-1-oxopentyl)-, (3aS-(3aalpha,4beta,6aalpha))-
- N(epsilon)-biotinyl-L-lysine
- SCHEMBL305707
- N-biotinyl-L-lysine
- Biocytin, >=98% (TLC)
- L-Lysine,N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
- 576-19-2
- HB5035
- N6-BIOTINYLLYSINE
- N(6)-D-biotinyl-L-lysine
- BAQMYDQNMFBZNA-MNXVOIDGSA-N
- UNII-G6D6147J22
- s9886
- A869630
- MFCD00077319
- N-epsilon-Biotin-L-lysine
- N~6~-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}-L-lysine
- N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine
- N(SUP 6)-(5-((3AS,4S,6AR)-HEXAHYDRO-2-OXO-1H-THIENO(3,4-D)IMIDAZOL-4-YL)-1-OXOPENTYL)-L-LYSINE
- BP-23273
- epsilon-N-biotinyllysine
- L-Lysine, N6-(5-((3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno(3,4-d)imidazol-4-yl)-1-oxopentyl)-
- N(6)-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}-L-lysine
- CS-7587
- (2S)-6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-azaniumylhexanoate
- DA-71491
- (2S)-6-(5-((3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-4-yl)pentanoylamino)-2-aminohexanoic acid
- N(6)-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno(3,4-d)imidazol-4-yl)pentanoyl)-L-lysine
- (2S)-6-(5-((3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno(3,4-d)imidazolidin-4-yl)pentanamido)-2-aminohexanoic acid
- (2S)-6-(5-((3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-4-yl)pentanoylamino)-2-azaniumylhexanoate
- (3AS-(3aalpha,4b,6aalpha))-N(6)-(5-(hexahydro-2-oxo-1H-thieno(3,4-D)imidazol-4-yl)-1-oxopentyl)-L-lysine
- L-Lysine, N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
- (3AS-(3aalpha,4I2,6aalpha))-N(6)-(5-(hexahydro-2-oxo-1H-thieno(3,4-D)imidazol-4-yl)-1-oxopentyl)-L-lysine
- N6-[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-lysine;Ne-biotinyl-L-lysine
- FB18605
- MDL： MFCD00077319
- Inchi： 1S/C16H28N4O4S/c17-10(15(22)23)5-3-4-8-18-13(21)7-2-1-6-12-14-11(9-25-12)19-16(24)20-14/h10-12,14H,1-9,17H2,(H,18,21)(H,22,23)(H2,19,20,24)/t10-,11-,12-,14-/m0/s1
- InChI Key： BAQMYDQNMFBZNA-MNXVOIDGSA-N
- SMILES： S1C[C@H]2[C@@H]([C@@H]1CCCCC(NCCCC[C@@H](C(=O)O)N)=O)NC(N2)=O

Computed Properties

Exact Mass: 372.18300
Monoisotopic Mass: 372.18312656g/mol
Isotope Atom Count: 0
Hydrogen Bond Donor Count: 5
Hydrogen Bond Acceptor Count: 6
Heavy Atom Count: 25
Rotatable Bond Count: 11
Complexity: 491
Covalently-Bonded Unit Count: 1
Defined Atom Stereocenter Count: 4
Undefined Atom Stereocenter Count : 0
Defined Bond Stereocenter Count: 0
Undefined Bond Stereocenter Count: 0
Surface Charge: 0
Tautomer Count: 6
XLogP3: -2.4
Topological Polar Surface Area: 159

Experimental Properties

Color/Form: Crystallization. It is hydrolyzed into biotin and L-Lysine in case of strong acid.
Density: 1.234
Melting Point: ~245?°C (dec.) (lit.)
Boiling Point: 748.0±60.0 °C at 760 mmHg
Flash Point: 406.2±32.9 °C
PSA: 158.85000
LogP: 2.15940
Solubility: It is easily soluble in water, glacial acetic acid, slightly soluble in ethanol, and almost insoluble in acetone and most other organic solvents.
Merck: 13,1227
Specific Rotation: D25 +53° (c = 1.05 in 0.1N NaOH)
Optical Activity: [α]20/D +53°, c =?1.05% in 0.1 M NaOH(lit.)
Vapor Pressure: 0.0±5.4 mmHg at 25°C

(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid Security Information

Signal Word：warning
Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
Warning Statement： P264+P280+P305+P351+P338+P337+P313
Hazardous Material transportation number：NONH for all modes of transport
WGK Germany：3
Safety Instruction： H303+H313+H333
Storage Condition：Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month

(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid Pricemore >>

Related Categories	No.	Product Name	Cas No.	Purity	Specification	Price	update time
Chemenu	CM129320-1g	N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine	576-19-2	95%	1g	$355	2021-06-09
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.	B4261-5MG	(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid	576-19-2		5mg	￥649.86	2024-12-24
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.	B4261-25MG	(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid	576-19-2		25mg	￥1225.08	2024-12-24
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.	B4261-50MG	(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid	576-19-2		50mg	￥1776.63	2024-12-24
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.	B4261-100MG	(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid	576-19-2		100mg	￥2730.43	2024-12-24
XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd.	B4261-250MG	(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid	576-19-2		250mg	￥6097.94	2024-12-24
TRC	B388100-10mg	Biocytin	576-19-2		10mg	$ 63.00	2023-04-18
TRC	B388100-25mg	Biocytin	576-19-2		25mg	$ 74.00	2023-04-18
TRC	B388100-50mg	Biocytin	576-19-2		50mg	$ 102.00	2023-04-18
TRC	B388100-100mg	Biocytin	576-19-2		100mg	$ 153.00	2023-04-18

(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid Production Method

(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid Suppliers

Amadis Chemical Company Limited

Gold Member

Audited Supplier

(CAS:576-19-2)(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid

Order Number:A869630

Stock Status:in Stock

Quantity:1g

Purity:99%

Pricing Information Last Updated:Friday, 30 August 2024 09:18

Price ($):348.0

Email:[email protected]

Product Official Link

(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid Related Literature

1. Dissolution of cork biopolymers in biocompatible ionic liquids

Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?

Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices

Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?

Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?

Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

Related Categories

Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

576-19-2 ((2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid) Related Products

Recommended suppliers